ANTXR1 has been reported to participate in tumor progression in numerous kinds of carcinomas, and its overexpression in tumor cells makes it a promising prognostic biomarker and therapeutic target accordingly (Chaudhary et al., 2012). Here, ANTXR1 is linked to carcinoma.